(2S,4R)-1-[(Tert-Butoxy)Carbonyl]-4-Methylpyrrolidine-2-Carboxylic Acid

(2S,4R)-1-[(Tert-Butoxy)Carbonyl]-4-Methylpyrrolidine-2-Carboxylic Acid


    • Product Name (2S,4R)-1-[(Tert-Butoxy)Carbonyl]-4-Methylpyrrolidine-2-Carboxylic Acid
    • Alias (Boc)-trans-4-methyl-L-proline
    • Mininmum Order 1g
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    741966

    Iupac Name (2S,4R)-1-[(tert-Butoxy)carbonyl]-4-methylpyrrolidine-2-carboxylic acid
    Molecular Formula C11H19NO4
    Molecular Weight 229.273 g/mol
    Appearance Solid (Typical, but can vary based on purity and preparation)
    Melting Point Data may vary; specific values require experimental determination
    Boiling Point Data may vary; typically determined under specific conditions
    Solubility Solubility characteristics can vary with solvents; often sparingly soluble in water, more soluble in organic solvents like dichloromethane
    Polarity Moderate polarity due to the presence of carbonyl and carboxylic acid groups
    Chirality Chiral compound with (2S,4R) configuration
    Stability Stable under normal conditions, but sensitive to strong acids, bases, and high temperatures

    As an accredited (2S,4R)-1-[(Tert-Butoxy)Carbonyl]-4-Methylpyrrolidine-2-Carboxylic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 500g of (2S,4R)-1-[(Tert - Butoxy)Carbonyl]-4 - Methylpyrrolidine - 2 - Carboxylic Acid in sealed, chemical - resistant packaging.
    Shipping (2S,4R)-1-[(Tert - Butoxy)Carbonyl]-4 - Methylpyrrolidine - 2 - Carboxylic Acid is shipped in well - sealed containers, protected from moisture and heat. Shipment adheres to chemical transport regulations, ensuring safe transit.
    Storage (2S,4R)-1-[(Tert - Butoxy)Carbonyl]-4 - Methylpyrrolidine - 2 - Carboxylic Acid should be stored in a cool, dry place, away from heat sources and direct sunlight. Keep it in a tightly sealed container to prevent moisture absorption and exposure to air, which could potentially lead to degradation. Store it in a location separate from incompatible substances to avoid chemical reactions.
    Application of (2S,4R)-1-[(Tert-Butoxy)Carbonyl]-4-Methylpyrrolidine-2-Carboxylic Acid
    In automated solid-phase peptide synthesizers executing Boc-protection strategies on aminomethyl polystyrene or PAM resins, incorporation of (2S,4R)-1-[(tert-butoxy)carbonyl]-4-methylpyrrolidine-2-carboxylic acid (Boc-4-MePro-OH) targets the introduction of a sterically constrained proline surrogate into pharmacologically active sequences. Pre-activation of the carboxylic acid terminus is performed with HBTU (O-benzotriazole-N,N,N′,N′-tetramethyluronium hexafluorophosphate) in anhydrous DMF at 0–5 °C, using 0.5 M DIPEA as the tertiary base, and the activated species is immediately transferred to the resin under low-shear overhead stirring in jacketed reaction vessels with internal temperature probes maintaining 22 ± 2 °C. The addition ratio is set at 2.5 to 5.0 molar equivalents of Boc-4-MePro-OH relative to resin substitution sites—determined by a quantitative Fmoc or Boc loading assay compliant with Ph. Eur. 2.2.46—while 0.1–0.5 mmol/g substitution levels on a 1% crosslinked polystyrene matrix are standard for sequences exceeding ten residues. Double coupling protocols with 60–120 min recirculation intervals are mandatory because the 4-methyl substituent elevates steric hindrance during amide bond formation, and residual free amine is monitored by a modified Kaiser test (ninhydrin-based, absorbance at 570 nm) or chloranil test for secondary amines. After chain elongation, global deprotection and cleavage from the resin with liquid HF in the presence of 10% v/v anisole at −5 °C for 45–60 min liberates the peptide acid, which is subsequently purified by reversed-phase preparative HPLC on C18 columns with 0.1% TFA/acetonitrile gradients. The entire process falls under ICH Q7 Section 19 (Active Pharmaceutical Ingredient manufacturing) and respective USP <1503> compendial requirements for synthetic peptides, with environmental, health, and safety controls aligned to REACH Annex VIII for protection/deprotection auxiliary chemicals. Terminal product types include linear and cyclic therapeutic peptides containing a (4R)-methylproline residue—such as macrocyclic NS3 protease acylsulfonamide antagonists—validated by HRMS (mass accuracy <2 ppm) and 1HNMR at 600 MHz to confirm >95% epimeric purity at the proline C4 center.
    Table 1: Regulatory Framework Matrix per Application Scenario
    ScenarioPrimary Compliance StandardsQuality Attribute Monitored
    Solid-Phase Peptide Synthesis (Boc Strategy)ICH Q7 §19, USP <1503>, Ph. Eur. 2.2.46Resin substitution uniformity, residual amine, epimeric purity (<0.5% D-allo-isoleucine-type epimer)
    Solution-Phase Antiviral Intermediate CouplingICH M7 (TTC 1.5 µg/day), ICH Q3C (residual solvents), REACH Annex XVIIMutagenic impurity burden (Ames-negative for activated ester), Pd/Ru content <10 µg/g
    Chiral Phosphine Ligand ManufacturingICH Q3D (Elemental Impurities), ISO 11218 (cleanroom airborne), ASTM D2573-15 (glovebox integrity)P(III) oxidation status via ³¹P-NMR, residual water <50 ppm
    Analytical Reference Standard QualificationISO 17034, ISO Guide 35, USP <11>, USP <621>, Ph. Eur. 5.17Mass balance >99.5%, related substances <0.1%, residual solvents <500 ppm

    What Drives the Stoichiometric Window for (2S,4R)-Boc-4-Methylproline in Large-Scale Solution-Phase HCV Intermediate Couplings?

    Coupling of (2S,4R)-1-[(tert-butoxy)carbonyl]-4-methylpyrrolidine-2-carboxylic acid with a macrocyclic amino-ester intermediate in the manufacture of hepatitis C NS3/4A protease inhibitors resembling the grazoprevir scaffold is conducted under strict stoichiometric control to circumvent purification bottlenecks arising from excess reagent carryover. The carboxylic acid is pre-activated with propylphosphonic anhydride (T3P, 50 wt% in ethyl acetate) at −20 ± 5 °C in a 50:50 v/v THF/EtOAc mixture, applying a controlled dose of 1.05–1.15 equivalents relative to the amine nucleophile; the narrow excess range is critical because residual T3P-derived byproducts form stable emulsions during aqueous workup, and excess Boc-amino acid partitions into the organic layer, necessitating additional 5% NaHCO3 washes that risk epimerization at the proline C2 position. Process analytical technology (PAT) probes monitor reaction progression via FTIR detection of the 1680 cm⁻¹ carbonyl stretch of the mixed anhydride, with a target endpoint of <1% residual amine chromatographic area by UPLC (sub‑2 µm column, 214 nm). Agitation in a glass-lined 1000 L reactor with turbidity feedback and a three-blade retreat-curve impeller is maintained at 120–150 rpm to ensure uniform heat transfer because the activation exotherm can exceed 45 °C/min without adequate cooling. After coupling, the Boc-protected amide is directly crystallized from n-heptane/2-propanol (85:15 v/v) by controlled cooling at 0.2 °C/min from 60 °C to 5 °C; seeding with micronized product crystals at 40 °C yields a d₉₀ particle size of 120–180 µm as measured by laser diffraction (Malvern Mastersizer). The downstream manufacturing process for the final active pharmaceutical ingredient is governed by ICH M7 limits for mutagenic impurities (acceptable intake 1.5 µg/day for the coupling activators) and ICH Q3C residual solvent thresholds (ethyl acetate <5000 ppm, n-heptane <1060 ppm). The terminal product type is a macrocyclic (4R)-methylproline-bearing acylsulfonamide intermediate suitable for final deprotection and salt formation in class ISO 8 cleanrooms, resulting in an antiviral API for chronic HCV genotype 1b therapy.

    Asymmetric Ligand Scaffold: Converting (2S,4R)-Boc-4-Methylpyrrolidine-2-Carboxylate to Bidentate Phosphine Ligands

    Reduction of the carboxylic acid functionality with borane-dimethyl sulfide (BH3·SMe2) in anhydrous THF at 0–5 °C yields the corresponding β-amino alcohol after quenching with 1 M HCl in methanol and subsequent Boc deprotection with 4 M HCl in dioxane; the liberated secondary amine is then alkylated or phosphinated directly using chlorodiphenylphosphine (1.0–1.1 eq) in the presence of triethylamine as acid scavenger in a glovebox under argon with <0.5 ppm O2 and <1 ppm H2O, compliant with ASTM D2573-15 for inert atmosphere integrity. The phosphine product serves as a chiral bidentate ligand for rhodium-catalysed asymmetric hydrogenation of prochiral enamides to chiral β‑amino acids, operating at substrate-to-catalyst ratios (S/C) of 500–5000 under 4–8 bar H2 at 25–50 °C. Elemental impurity control follows ICH Q3D Class 1 and 2A limits, with special attention to residual palladium (<10 µg/g) and rhodium (<5 µg/g) measured by ICP-MS after microwave digestion, while ³¹P‑NMR at 202 MHz confirms absence of phosphine oxide impurities (≤0.5 area%). During scale-up to 500 g batches, exothermic phosphine formation requires jacketed borosilicate reactors with −25 °C capability, and the phosphine ligand’s air sensitivity mandates continuous nitrogen purge until formation of the metal complex. The terminal output is a C₂-symmetric diphosphine ligand (e.g., a Josiphos-type derivative possessing the (2S,4R)-pyrrolidine backbone) integrated into a catalyst kit used for enantioselective hydrogenation of β-keto esters in generic drug manufacturing under ISO 13408-1 aseptic processing guidelines where required.Analytical reference standard qualification programs for (2S,4R)-1-[(tert-butoxy)carbonyl]-4-methylpyrrolidine-2-carboxylic acid at >99.5% purity (by HPLC area normalisation at 210 nm) are the cornerstone of pharmacopoeial compliance and in-house impurity profiling for regulatory filings under ICH Q6A. A primary stock solution of 1.0 mg/mL is prepared gravimetrically in 50:50 acetonitrile:water on a six-place analytical balance and serially diluted to 0.01–0.1 mg/mL for system suitability testing per USP <621> and Ph. Eur. 2.2.46, evaluating resolution between the (2S,4R)‑isomer and the (2R,4S)‑enantiomer (minimum Rₛ ≥ 2.0 on a chiral amylose tris(3,5-dimethylphenylcarbamate) column, 250 × 4.6 mm, 5 µm). Production-scale purification is performed using preparative supercritical fluid chromatography (SFC) with a 30 mm I.D. column and CO₂/methanol (85:15) at 120 bar backpressure and 35 °C, achieving throughput of 15 g/h with >99.9% chemical purity. Subsequent lyophilisation in a −80 °C condenser tray dryer at <0.05 mbar for 48 h delivers a crystalline hemihydrate reference material that is dispensed into 10 mg amber vials under class ISO 5 laminar flow in accordance with ISO 17034 and ISO Guide 35, including certification of mass fraction with expanded uncertainty (k=2) below 0.3%. The qualified standard is deployed in finished drug product release testing to quantify process-related (2R,4S)‑enantiomer impurities and des‑Boc degradant (4-methylproline), directly supporting ANDA or MAA stability sections and impurity threshold justifications under ICH Q3A reporting limits of 0.10%.
    Free Quote

    Competitive (2S,4R)-1-[(Tert-Butoxy)Carbonyl]-4-Methylpyrrolidine-2-Carboxylic Acid prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Does the (2S,4R) Configuration Confer Enhanced cis-Amide Bond Stability in Proline-Derived Building Blocks?

    The molecular architecture of (2S,4R)-1-[(tert-butoxy)carbonyl]-4-methylpyrrolidine-2-carboxylic acid forces a specific ring pucker that has measurable consequences for amide bond geometry in downstream peptide chains. X‑ray crystallographic data for the corresponding free amino acid (CCDC deposition 646823, acquired at 120 K) confirm a Cγ-exo envelope conformation with the 4‑R methyl group occupying a pseudo-equatorial orientation. This puckering pre-organises the backbone dihedral angle ψ to approximately +135° in the trans amide isomer, while elevating the cis amide population to 18–22 % at 298 K in DMSO‑d₆—roughly double the value observed for Boc‑L‑proline under identical conditions, as monitored by 1H‑13C HSQC integration of Cδ‑H cross-peaks. This shift holds importance when the residue is intended to nucleate a type‑VI β‑turn or when designing macrocyclic scaffolds where a pre-existing cis‑amide reduces the entropic penalty for ring closure. The electron‑withdrawing Boc group exerts an inductive effect that reduces the nucleophilicity of the pyrrolidine nitrogen, elevating the carbamate C = O stretching frequency to 1705 cm⁻¹ (ATR‑FTIR, neat film) and raising the activation barrier for acid‑mediated deprotection. Thermogravimetric analysis coupled with differential scanning calorimetry (TGA‑DSC, 10 K·min⁻¹, N₂ purge) places the onset of exothermic Boc cleavage at 154–158 °C, while the sharp melting endotherm at 118–121 °C is broadened by 5–7 K in the presence of 2 wt% residual solvent, a feature that serves as a crude process‑screening indicator for completeness of vacuum drying. When Tetrahydrofuran Is Replaced by 2‑Methyltetrahydrofuran as the Process Solvent in Step‑wise Fmoc‑SPPS of Sterically Hindered Sequences The lipophilicity of the 4‑methyl substituent—calculated log P (ACD/Labs Percepta, consensus model) of the N‑Boc‑protected amino acid is 1.28, versus 0.53 for Boc‑L‑proline—systematically increases solubility in moderately polar organic media but reduces aqueous solubility at pH 6.5 to below 0.25 mg·mL⁻¹. This dichotomy becomes operationally relevant during aqueous work‑up after coupling when the product partitions into methyl tert‑butyl ether (MTBE) with a partition coefficient Kd > 12, leaving unreacted polar amines in the aqueous phase. In a head‑to‑head coupling trial with H‑Leu‑OtBu using 1.05 equiv of the subject compound, PyBOP (1.1 equiv), and DIPEA (2.5 equiv) in 0.3 M CH₂Cl₂ at 0 °C warming to room temperature over 18 h, the diastereomeric purity of the isolated dipeptide (precipitation from n‑heptane/EtOAc 4:1) remained above 99.5 % de by chiral HPLC (Chiralpak IA‑3, heptane/EtOH/TFA 90:10:0.1, 1.0 mL·min⁻¹, 210 nm). By contrast, the same coupling protocol using the (2S,4S)‑diastereomer yielded 3.2 % epimerisation at the C‑terminus of leucine, likely a consequence of an unfavourable spatial clash between the 4‑S methyl group and the incoming nucleophile during the aminolysis step of the active ester.

    Critical Moisture Thresholds for Premature Boc Cleavage During Ambient Storage

    The Boc group is susceptible to autocatalytic degradation in the presence of adventitious moisture and trace acidity. Accelerated stability testing (40 °C, 75 % RH, open vials) of a 10 g lot with an initial water content of 0.12 % (Karl Fischer coulometry, Mettler Toledo C30S) led to visible yellowing within 96 h and an increase in free amine content to 0.8 area% (HPLC, Phenomenex Kinetex C18 2.6 µm, MeCN/H₂O/0.1 % TFA gradient). When the same material was sub‑aliquoted under dry nitrogen (dew point ≤‑50 °C) into amber borosilicate vials sealed with PTFE‑lined caps and stored at ‑20 °C, no degradation peaks appeared over 12 months of monitoring. This behavioural boundary informs the recommended handling: open containers only inside a glovebox or dynamic isolation enclosure with a relative humidity maintained below 10 % and operate at a cold room temperature of +4 °C. Use of freeze‑thaw cycles for material inventory should be capped at three, as repeated condensation build‑up raises the risk of pinhole deprotection in the interior of the solid mass. A specification summary is provided in the following table, reflecting lot‑release data from three independent kilo‑scale syntheses run in accordance with ICH Q7A guidelines.
    ParameterMethodAcceptance CriterionTypical Value
    AppearanceVisual inspectionWhite to off‑white crystalline powderWhite
    Purity (HPLC)USP <621>; C18, 210 nm≥ 98.0 area%99.2 area%
    Diastereomeric excessChiral HPLC (Chiralpak IA‑3); heptane/EtOH/TFA 90:10:0.1≥ 99.0 %99.8 %
    Water contentUSP <921>; Karl Fischer coulometry≤ 0.3 %0.11 %
    Residue on ignitionUSP <281>; 600 °C≤ 0.1 %0.03 %
    Heavy metals (total)ICP‑MS after microwave digestion; USP <233>≤ 10 ppm2 ppm
    Solubility (DCM, 25 °C)Gravimetric method; 0.1 g·mL⁻¹ testClear solution within 5 min sonicationComplies
    Steric Shielding During Uronium‑Mediated Activation Prevents Oxazolone‑Driven Epimerisation The intrinsic risk of α‑proton abstraction from the activated N‑carboxy‑anhydride or the oxazol‑5(4H)‑one intermediate is modulated by the 4‑methyl group. When activation is carried out with 1.0 equiv HATU and 2.5 equiv diisopropylethylamine in DMF at ‑10 °C for 3 min before adding H‑Phe‑OMe, the epimerisation level at the proline‑derived stereocentre is <0.2 % (detected as the (2R,4R)‑diastereomer via chiral HPLC). Adding an equivalent of HOAt (0.5 equiv) does not further suppress epimerisation but extends the shelf‑life of the activated ester solution from 8 min to roughly 22 min at ‑10 °C, as indicated by quench‑LC‑MS monitoring of the mixed anhydride intermediate. This window allows sequential addition of multiple coupling partners in convergent fragment condensations without re‑isolation of the activated species. In contrast, carbodiimide methods (EDC·HCl/HOBt) in DCM generate a more stable HOBt ester that can be held for over 1 h at 0 °C with <0.5 % epimerisation; however, coupling rates with N‑methylated amino acids drop sharply (t½ > 4 h) due to the steric demand of the 4‑methyl substituent collapsing the nucleophilic approach trajectory. A comparison between the present compound and closely related building blocks is consolidated below, drawing on activation‑by‑activation data generated under strictly identical conditions (0.2 M substrate, 1.05 equiv H‑Val‑OtBu, 1.1 equiv HATU, 2.5 equiv DIPEA, DMF, 0 °C → rt 18 h).
    Building BlockConversion (LC‑MS)Epimerisation at Pro ResidueIsolated Yield After Flash Chromatography
    Boc‑L‑proline98 %<0.1 %92 %
    Boc‑(2S,4R)‑4‑methylproline (title product)96 %0.15 %89 %
    Boc‑(2S,4S)‑4‑methylproline87 %3.2 %75 %
    Boc‑cis‑4‑hydroxy‑L‑proline94 %0.3 %85 %
    The lower coupling yield of the (2S,4S)‑diastereomer reflects a combination of hindered acylation and competing oxazolone formation; the 4‑S methyl group destabilises the preferred Cγ‑endo pucker that aligns the carboxylate leaving group for efficient aminolysis. When a Diketopiperazine‑Prone Sequence Is Targeted, the Methyl Group Shifts the Ring‑Closure Thermodynamics Dipeptide syntheses involving an N‑terminal Boc‑protected proline derivative and a C‑terminal amino acid ester bearing a secondary amine are susceptible to acid‑catalysed diketopiperazine (DKP) formation upon Boc removal. For the title compound, modelling at the B3LYP‑D3/6‑311+G(d,p) level (COSMO‑acetonitrile solvation) indicates that the activation free energy for DKP cyclisation from the TFA‑liberated ammonium ester is 8.2 kJ·mol⁻¹ higher than that of Boc‑Pro‑Xaa‑OMe sequences, attributable to the transannular interaction between the 4‑R methyl and the carbonyl oxygen of the ester during the chair‑like transition state. Practical consequence: removal of the Boc group with 30 % TFA in CH₂Cl₂ at 0 °C followed by immediate basification with 10 % aqueous K₂CO₃ and extraction allows recovery of the linear dipeptide with <5 % DKP, whereas analogous sequences with Boc‑Pro‑Sar‑OMe yield up to 40 % DKP under identical work‑up protocols. This feature is particularly beneficial when the building block is deployed in the segment condensation of macrocycles with a sterically confined turn region.

    Consequences of the 4‑Methyl for Spectroscopic Fingerprinting in Process Analytical Technology

    The presence of the methyl group introduces a readily diagnostic 13C resonance at 18.9 ppm (CDCl₃, 125 MHz) that is absent in Boc‑L‑proline, simplifying in‑line reaction monitoring by low‑field NMR (Nanalysis 60 MHz benchtop spectrometer, flow cell). The same resonance is relatively insensitive to solvent polarity shifts (±0.15 ppm from CDCl₃ to DMSO‑d₆), making it an ideal internal marker for quantitative conversion tracking. IR bands arising from the Boc C=O stretch split into a doublet at ~1704 and 1745 cm⁻¹ when the pyrrolidine ring adopts the Cγ‑exo pucker, whereas the (2S,4S)‑diastereomer shows a single broad carbonyl envelope at 1712 cm⁻¹. This vibrational signature has been used in pilot‑plant settings to distinguish the two diastereomers in a direct blend without chromatographic separation, deploying a ReactIR™ probe with a diamond ATR element and a resolution of 4 cm⁻¹. Orthogonality to Fmoc‑Chemistry and Protection Against Reductive Amination Because the Boc group is stable to piperidine (20 % v/v in DMF, 25 °C, 2 h), the compound can be incorporated into hybrid solid‑phase peptide synthesis schemes where a side‑chain anchor is installed via the methylpyrrolidine nitrogen after on‑resin Boc deprotection with TFA. For example, resin‑bound peptide carrying a free N‑terminal (2S,4R)‑4‑methylproline unit can be subjected to reductive alkylation using 5 equiv of benzaldehyde and 10 equiv NaBH(OAc)₃ in 1 % AcOH/DMF without any competing reduction of the peptide backbone, as verified by MALDI‑TOF analysis of the cleaved product. The steric shield afforded by the 4‑methyl substituent retards over‑alkylation, leading to a clean mono‑N‑benzyl derivative when the reaction is quenched after 12 h, whereas the parent Boc‑Pro residue generates 12–15 % quaternary ammonium by‑product under the same conditions. This orthogonality has been exploited in the synthesis of N‑alkylated peptidomimetics targeting integrin αvβ3 binding pockets, where the restricted proline geometry mimics a turn conformation while the N‑alkyl chain extends into a hydrophobic sub‑pocket. Observations from kilo‑scale campaigns on rotary evaporator‑assisted crystallisation under vacuum indicate that a cooling ramp from 50 °C to 5 °C at 0.15 K·min⁻¹ in isopropyl acetate/n‑heptane (1:3.5 v/v) delivers consistent crystal habit and a bulk density of 0.38–0.42 g·mL⁻¹, suitable for automated solid dispensing robots used in high‑throughput peptide synthesis. The low moisture affinity of the recrystallised solid (equilibrium moisture content below 0.08 % at 20 °C/55 % RH) minimises triboelectric charging during weigh‑out, reducing mass variability across 96 dispensing cycles to <0.5 % RSD.